Presença de inibidores de proteases em amostras comerciais de “faseolaminas” utilizadas como bloqueadores de carboidratos e os riscos à saúde
PDF (Português (Brasil))

Palabras clave

faseolamina
inibidores de proteases
inibidores de tripsina
bloqueadores de carboidratos
inibidores de amilase
pâncreas

Cómo citar

1.
Murra M dos S, Pessato TB, Tavano OL. Presença de inibidores de proteases em amostras comerciais de “faseolaminas” utilizadas como bloqueadores de carboidratos e os riscos à saúde. Rev Inst Adolfo Lutz [Internet]. 22 de marzo de 2013 [citado 23 de noviembre de 2024];72(3):198-205. Disponible en: https://periodicos.saude.sp.gov.br/RIAL/article/view/32918

Resumen

Foi investigada a veiculação de inibidores de proteases, concomitante ao consumo de “faseolamina”, cuja ingestão diária e de maneira prolongada poderia estar associada ao risco no desenvolvimento de alterações morfológicas e metabólicas de pâncreas. Dez amostras foram obtidas em farmácias de manipulação no município de Uberaba – MG, as quais são comercializadas na forma de cápsulas como “faseolamina” e uma como “farinha de feijão branco”, além de amostra de farinha preparada a partir da trituração de feijões brancos (Phaseolus vulgaris) obtidos comercialmente, sem qualquer processamento. Estas amostras foram analisadas efetuando-se a determinação de atividade de inibidores de tripsina, a determinação de proteínas totais e de atividade de inibição de amilase. Todas as amostras estudadas apresentaram atividades de
inibição de tripsina, porém com baixa ou mesmo inexistente inibição de amilase; e em algumas amostras foi detectada concentração de proteínas muito inferior ao esperado. Uma vez observada a presença de atividade de inibição de tripsina em todas as amostras estudadas, e pela inexistência de níveis seguros de consumo estabelecidos para o ser humano, e ainda baseando-se nos trabalhos sobre associação de ingestão prolongada destes inibidores com alterações de atividade pancreática, o consumo destes “bloqueadores de carboidratos” deveria ser melhor controlado.

https://doi.org/10.18241/0073-98552013721564
PDF (Português (Brasil))

Citas

1. Ferreira VA, Magalhães, R. Obesidade no Brasil: tendências atuais. Rev Port Saúde Publ. 2006; 24(2):71-81.

2. Ryan DH, Kushner R. The State of Obesity and Obesity Research. JAMA. 2010;304(16):1835-6.

3. Steyer TE, Ables A. Complementary and alternative therapies forweight loss. Prim Care Clin Office Pract. 2009; 36: 395-406.

4. Udani JK, Singh BB, Barrett ML, Preuss HG. Lowering the glycemic index of white bread using a white bean extract. Nutr J. 2009;8(52):1-5.

5. Chokshi D. Subchronic oral toxicity of a standardized white kidney bean (Phaseolus vulgaris) extract in rats. Food Chem Toxicol. 2007;45:32-40.

6. Marshall JJ, Lauda CM. Purification and Properties of Phaseolamin, an Inhibitor of α-Amylase, from the Kidney Bean (Phaseolus vulgaris). J Biol Chem.1975;250(20):8030-7.

7. Carlson GL, Li BUK, Bass P, Olsen WA. A Bean α-Amylase Inhibitor Formulation (Starch Blocker) Is Ineffective in Man. Science.1983;219:393-5.

8. Liener, IE. Toxic constituents of plants foods. 2ª ed. New York: Academic Press; 1980.

9. Liener IE, Donatucci DA, Tarcza JC. Starch blockers: a potential source of trypsin inhibitors and lectin. Am J Clin Nutr.1984; 39:196-200.

10. Deglaire A, Moughan PJ, Bos C, Tome D. Commercial Phaseolus vulgaris Extract (Starch Stopper) Increases Ileal Endogenous Amino Acid and Crude Protein Losses in the Growing Rat. J Agric Food Chem.2006;54:5197-202.

11. Holm H, Krogdahl A, Hansen LE. High and Low Inhibitor Soybean Meals Affect Human Duodenal Proteinase Activity Differently: In Vitro Comparison of Proteinase Inhibition. J Nutr.1998;118:521-5.

12. Reseland JE, Holm H, Jacobsen MB, Jenssen TG, Hanssen LE. Proteinase inhibitors induce selective stimulation of human trypsin and chymotrypsin secretion. J Nutr.1996;126(3):634-42.

13. Liener IE. Possible adverse effects of soybean anticarcinogens. J Nutr.1995;125(3):S:744-9.

14. Liener IE. Soybean protease inhibitors and pancreatic carcinogenesis. J Nutr.1996;126(2):582-3.

15. Liener IE. Trypsin inhibitors: concern of human nutrition or not? J Nutr.1986; 116(5):920-3.

16. Roebuck BD. Trypsin inhibitors: potential concern for humans?. J Nutr.1987;117(2):398-400.

17. Friess H, Kleeff J, Isenmann R, Malfertheiner P, Büchler MW. Adaptation of the Human Pancreas to Inhibition of Luminal Proteolytic Activity. Gastroenterol.1998;115(2):388-96.

18. Durigan JF, Sgarbieri,VC, Bulisani EA. Protein value of dry bean cultivars; factors interfering with biological utilization. J Agric Food Chem.1987;2(35):694-8.

19. Silva MR, Silva MAAP. Fatores antinutricionais: inibidores de proteases e lectinas. Rev Nutr.2000;13(1):3-9.

20. Al-Wesali M, Lambert N, Welham T, Domoney C. The influence of pea seed trypsin inhibitors on the in vitro digestibility of casein. J Sci Food Agric.1995;68(4):431-7.

21. Antunes PL, Sgarbieri VC. Effect of heat treatment on the toxicity value of dry bean (Phaseolus vulgaris var. Rosinha G2) proteins. J Agric Food Chem.1980;28(5):935-8.

22. Egbe IA, Akinyele IO. Effect of cooking on the antinutritional factors of lima beans (Phaseolus lunatus). Food Chem.1990;35:81-7.

23. Khattab RY, Arntfield SD. Nutritional quality of legume seeds as affected by some physical treatments 2. Antinutritional factors. Food Sci Technol.2009;42:1113-8.

24. Mulimani VH, Paramjyothi S. Effect of heat and u.v. on trypsin and chymotrypsin inhibitor activities in redgram (Cajanus cajan NCAL.). J Food Sci Technol.1993;30(1):62-3.

25. Shimelis EA, Rakshit SK. Effect of processing on antinutrients and in vitro protein digestibility of kidney bean (Phaseolus vulgaris L.) varieties grown in East África. Food Chem.2007;103:161-72.

26. Wang N, Hatcher DW, Tyler RT, Toews R, Gawalko EJ. Effect of cooking on the composition of beans (Phaseolus vulgaris L.) and chickpeas (Cicer arietinum L.). Food Res Int.2010;43:589–94.

27. Kakade ML, Rackis JJ, Mcghee JE, Puski G. Determination of trypsin inhibitor activity of soy products: a collaborative analysis of an improved procedure. Am Assoc Cereal Chem.1974;51:376-82.

28. Mosca M, Boniglia C, Carrat B, Giammarioli S, Nera V, Sanzini E. Determination of a-amylase inhibitor activity of phaseolamin from kidney bean (Phaseolus vulgaris) in dietary supplements by HPAEC-PAD. Anal Chim Acta.2008;617:192–5.

29. Association of Analytical Communities - AOAC. Official Methods of Analysis. 15th ed. Arlington, VA, 1990

30. Pires CV, Oliveira MGA, Cruz GADR, Mendes FQ, Rezende ST, Moreira MA. Composição físico-química de diferentes cultivares de feijão (Phaseolus vulgaris L.). Alim Nutr.2005;16(2):157-62.

31. Tavano OL, Silva Junior SI, Demonte A, Neves VA. Pancreatic hypertrophy in rats caused by chickpea (Cicer arietinum L.) protein intake. Alim Nutr.2005;16(1):5-10.

32. Gumbmann MR, Dugan GM, Spangler WL, Baker EC, Rackis JJ Pancreatic response in rats and mice to trypsin inhibitors from soy and potato after short- and long-term dietary exposure. J Nutr.1989;119(11):1598-607.

33. Mills PK, Beeson WL, Abbey DE, Fraser GE, Phillips RL. Dietary Habits and Past Medical History as Related to Fatal Pancreas Cancer Risk Among Adventists. Cancer.1988;61:2578-85.

34. Roebuck BD, Kaplita PV, Edwards BR, Praissman M. Effects of Dietary Fats and Soybean Protein on Azaserine-induced Pancreatic Carcinogenesis and Plasma Cholecystokinin in the Rat. Cancer Res.1987;1(47):1333-8.

35. Green GM, Lyman RL. Feedback regulation of pancreatic enzyme secretion as a mechanism for trypsin induced hypersecretion in the rat. Proc Soc Exp Biol Med.1972;140:6-12.

36. Fushiki T, Iwai K. Two hypotheses on the feedback regulation of pancreatic enzyme secretion. Faseb J.1989;3:121-6.

37. Gride JR. Role of Cholecystokinin in the Regulation of Gastrointestinal Motility. J Nutr.1994;124(8):S:1334-9.

38. Owyang C. Negative Feedback Control of Exocrine Pancreatic Secretion: Role of Cholecystokinin and Cholinergic Pathway. J Nutr.1994;124(8):S:1321-6.

39. Reidelberger RD. Cholecystokinin and Control of Food Intake. J Nutr.1994;124(8):S:1327-33.

40. Liddle RA. Regulation of Cholecystokinin Synthesis and Secretion in Rat Intestine. J Nutr.1994;124(8):S:1308-14.

41. Shrikhande SV, Barreto G, Koliopanos A. Pancreatic carcinogenesis: The impact of chronic pancreatitis and its clinical relevance. Indian J Cancer.2009;46(4):288-96.

42. Weder JK, Kahleyss R. Reaction of lentil trypsin-chymotrypsin inhibitors with human and bovine proteinases. J Agric Food Chem.2003;51(27):8045-50.

43. Nit, CA, Plahar WA. Cowpea Inhibition of human and bovine protease activities and the effects of processing. Food Control.1996;7(3):129-33.

Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.

Derechos de autor 2013 Revista del Instituto Adolfo Lutz

Descargas

Los datos de descargas todavía no están disponibles.